Tandem mass spectrometry combined with Fourier transform ion cyclotron resonance (FT-ICR) has been the basis for rationalizing the fragmentation mechanisms of anti-fungal macrolides nystatin A1, amphotericin B and pimaricin. The positive ion mass spectra were not informative, however, the dissociation of deprotonated molecules led to structurally significant ring-opened fragments. Using this approach of tandem FT-ICR mass spectrometry and electrospray ionisation coupled with high-performance liquid chromatography (HPLC), 11 macrolide natural analogues or degradation products were characterised in the nystatin mixture.
JonsbuE.McIntyreM.NielsenJ., “The influence of carbon sources and morphology on nystatin production by Streptomyces noursei”, J. Biotechnol.95, 133–144 (2002). doi: 10.1016/S0168-1656(02)00003-2
3.
BrautasetT.SekurovaO.N.SlettaH.EllingsenT.E.StromA.R.VallaS.ZotchevS.B., “Biosynthesis of the polyene anti-fungal antibiotic nystatin in Streptomyces noursei ATCC 11455: Analysis of the gene cluster and deduction of the biosynthetic pathway”, Chem. Biol.7, 395–403 (2000). doi: 10.1016/S1074-5521(00)00120-4
4.
BekerskyI.FieldingR.M.DresslerD.E.LeeJ.W.BuellD.N.WalshT.J., “Pharmacokinetics, excretion, and mass balance of liposomal amphotericin B (AmBisome) and amphotericin B deoxycholate in humans”, Antimicrobial Agents and Chemotherapy46, 828–833 (2002). doi: 10.1128/AAC.46.3.828-833.2002
5.
HaegeleK.D.DesiderioD., “The structural elucidation of polyene macrolide antibiotics by mass spectrometry. Nystatin, amphotericin B and pimaricin”, Biomed. Mass Spectrom.1, 20–28 (1974). doi: 10.1002/bms.1200010107
6.
LiJ.ZhuH.Q.LiJ.Y.JinS.H.HuC.Q., “Isolation, structure elucidation and activity of an unknown impurity of amphotericin B”, J. Antibiot.60, 272–276 (2007). doi: 10.1038/ja.2007.34
7.
CarmodyM.MurphyB.ByrneB.PowerP.RaiD.RawlingsB.CaffreyP., “Biosynthesis of amphotericin derivatives lacking exocyclic carboxyl groups”, J. Biol. Chem.280, 34420–34426 (2005). doi: 10.1074/jbc.M506689200
PawlakJ.SowinskiP.BorowskiE.GariboldiP., “Stereostructure and NMR characterization of the antibiotic candidin”, J. Antibiot.46, 1598–1604 (1993).
10.
LancelinJ.M.BeauJ.M., “Complete stereostructure of nystatin A1: A proton NMR study”, Tetrahedron Lett.30, 4521–4524 (1989). doi: 10.1016/S0040-4039(01)80734-6
11.
ZielinskiJ.GolikJ.PawlakJ.BorowskiE.FalkowskiL., “The structure of nystatin A3, a component of nystatin complex”, J. Antibiot.41, 1289–1291 (1988).
12.
SowinskiP.GariboldiP.CzerwinskiA.BorowskiE., “The structure of vacidin A, an aromatic heptaene macrolide antibiotic. I: Complete assignment of the 1H NMR spectrum and geometry of the polyene chromophore”, J. Antibiot.42, 1631–1638 (1989).
13.
SowinskiP.GariboldiP.PawlakJ.K.BorowskiE., “The structure of vacidin A, an aromatic heptaene macrolide antibiotic. II: Stereochemistry of the antibiotic”, J. Antibiot.42, 1639–1642 (1989).
14.
AszalosA.BaxA.BurlinsonN.RollerP.McNealC., “The structure of vacidin A, an aromatic heptaene macrolide antibiotic. II: Stereochemistry of the antibiotic”, J. Antibiot.38, 1699–1713 (1985).
15.
ZielinskiJ.JereczekE.SowinskiP.FalkowskiL.RudowskiA.BorowskiE., “The structure of a novel sugar component of polyene macrolide antibiotics: 2,6-dideoxy-l-ribohexopyranose”, J. Antibiot.32, 565–568 (1979).
16.
MendesM.V.RecioE.FoucesR.LuitenR.MartinJ.F.AparicioJ.F., “Engineered biosynthesis of novel polyenes: A pimaricin derivative produced by targeted gene disruption in Streptomyces natalensis”, Chem. Biol.8, 635–644 (2001). doi: 10.1016/S1074-5521(01)00033-3
17.
BerkenbuschT.BrucknerR., “Stereocontrolled synthesis of the C21–C38 fragment of the unnatural enantiomer of the antibiotic nystatin A1”, Chem. Eur. J.10, 1545–1557 (2004). doi: 10.1002/chem.200305540
18.
KadotaI.HuY.Q.PackardG.K.RychnovskyS.D., “A unified approach to polyene macrolides: Synthesis of candidin and nystatin polyols”, Proc. Natl. Acad. Sci. USA101, 11992–11995 (2004). doi: 10.1073/pnas.0401552101
19.
PrandiJ.BeauJ.M., “Stereostructure of nystatin A1: A synthetic assignment of the C1–C10 fragment”, Tetrahedron Lett.30, 4517–4520 (1989). doi: 10.1016/S0040-4039(01)80733-4
20.
LupanL.BandulaR.VasilescuM.BercuC., XXIX Colloquium Spectroscopicum Internationale (CSI-XXIX), Leipzig, Germany (1995).
21.
VolponL.LancelinJ.M., “Solution NMR structure of five representative glycosylated polyene macrolide antibiotics with a sterol-dependent anti-fungal activity”, Eur. J. Biochem.269, 4533–4541 (2002). doi: 10.1046/j.1432-1033.2002.03147.x
WangJ., “Analysis of macrolide antibiotics, using liquid chromatography-mass spectrometry, in food, biological and environmental matrices”, Mass Spectrom. Rev.28, 50–92 (2009). doi: 10.1002/mas.20189
24.
WorthenD.R.JayM.BummerP.M., “Methods for the recovery and purification of polyene anti-fungals”, Drug Dev. Ind. Pharm.27, 277–286 (2001). doi: 10.1081/DDC-100103727
25.
RaatikainenO., “High-performance liquid chromatography of heptaene polyenes: Assay of heptaene produced by Streptomyces griseoviridis”, J. Chromatogr.588, 356–360 (1991). doi: 10.1016/0021-9673(91)85047-J
26.
RaatikainenO.AuriolaS.TuomistoJ., “Identification of aromatic moieties and mycosamine in anti-fungal heptaenes with high-performance liquid chromatography, high-performance liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry”, J. Chromatogr.585, 247–254 (1991). doi: 10.1016/0021-9673(91)85084-S
27.
Ostrosky-ZeichnerL.BazemoreS.PaetznickV.L.RodriguezJ.R.ChenE.WallaceT.CossumP.RexJ.H., “Differential anti-fungal activity of isomeric forms of Nystatin”, Antimicrobial Agents and Chemotherapy45, 2781–2786 (2001). doi: 10.1128/AAC.45.10.2781-2786.2001
28.
ScheuchE.GiessmannT.SiegmundW., “Quantitative determination of nystatin in human plasma using LC–MS after inhalative administration in healthy subjects”, J. Chromatogr. B844, 84–88 (2006). doi: 10.1016/j.jchromb.2006.07.015
